Neuroscientific Biopharmaceuticals Ltd has released a press release.
Appendix 4D & Half-Year Financial Statements
Filed with ASX ·
6ix hasn’t read this filing yet.
Neuroscientific Biopharmaceuticals Ltd. on 6ix
Earlier from Neuroscientific Biopharmaceuticals
- Non-Renounceable Issue Prospectus
- NSB Research Collaboration
- NSB - Contract Research Agreement
- Pause In Trading
- Preliminary Final Report
Later from Neuroscientific Biopharmaceuticals
- NSB - Breakthrough results from Spinal Cord Injury Model
- NSB - FInal Data Received from Spinal Cord Injury Model
- NSB Receives R&D Advanced Overseas Finding
- EmtinB Can Become a Revolutionary Treatment for Glaucoma
- AGM Address
Follow Neuroscientific Biopharmaceuticals into a list and get an email when it puts out news.
Follow Neuroscientific Biopharmaceuticals